MEDINET Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended December 31, 2020
February 05, 2021 at 01:00 am EST
Share
MEDINET Co., Ltd. reported consolidated earnings results for the first quarter ended December 31, 2020. For the quarter, the company reported net sales of JPY 139 million compared to JPY 295 million a year ago. Operating loss was JPY 306 million compared to JPY 172 million a year ago. Ordinary loss was JPY 337 million against JPY 165 million a year ago. Loss was JPY 308 million compared to JPY 167 million a year ago. Basic loss per share was JPY 1.88 compared to JPY 1.35 a year ago.
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
MEDINET CO., LTD. 
